Melanoma: Only 20%-30% Of Melanoma Cases Start With Lesions Or Moles On Skin

Melanoma: Only 20%-30% Of Melanoma Cases Start With Lesions Or Moles On Skin In October 2023, Claire Turner and her husband, Mark, were taking their family on a weekend vacation. The 43-year-old mother of three, seated in the passenger seat, reached back to give her daughter some breakfast and felt as if she had pulled … Continue reading “Melanoma: Only 20%-30% Of Melanoma Cases Start With Lesions Or Moles On Skin”

A Scientist Experimented On Herself To Treat Her Stage-3 Breast Cancer. It Worked

A Scientist Experimented On Herself To Treat Her Stage-3 Breast Cancer. It Worked A scientist who experimented on herself and successfully treated her stage 3 breast cancer has ignited an ethical debate among researchers over self-experimentation in medicine. Beata Halassy, a virologist and head of a research unit at the University of Zagreb in Croatia, … Continue reading “A Scientist Experimented On Herself To Treat Her Stage-3 Breast Cancer. It Worked”

Immunotherapy drugs help cancer patients survive

Cancer Treatment That Helped Jimmy Carter With Brain Cancer In August 2015, former President Jimmy Carter had surgery to remove a mass from his liver. Tests that were done after surgery showed the mass turned out to be melanoma, the most serious type of skin cancer because it tends to metastasize or spread to other … Continue reading “Immunotherapy drugs help cancer patients survive”

Breast Cancer Blood Test Hailed As A Breakthrough

Breast Cancer Blood Test Hailed As A Breakthrough A new type of “ultra-sensitive” blood test can predict if breast cancer will return in high-risk patients long before they relapse and symptoms show up on scans, according to scientists at the Institute of Cancer Research (ICR) in London, England. The research team conducted a study using … Continue reading “Breast Cancer Blood Test Hailed As A Breakthrough”

Trial Results For New Lung Cancer Drug Are ‘Off The Charts’

Trial Results For New Lung Cancer Drug Are ‘Off The Charts’ Researchers and oncologists are encouraged by the “unprecedented” and “off the chart” trial results for a new lung cancer drug that can potentially extend the lives of people diagnosed with the disease. A recent study found the drug Lorlatinib improved survival rates by the … Continue reading “Trial Results For New Lung Cancer Drug Are ‘Off The Charts’”

Melanoma (Skin Cancer) Warning Signs

Melanoma (Skin Cancer) Warning Signs Skin cancer is the most common form of cancer, but melanoma is the most dangerous cancer because medical professionals say it can grow and spread quickly. Although melanoma accounts for only about 1 percent of skin cancers, it causes a large majority of skin cancer deaths, according to the American … Continue reading “Melanoma (Skin Cancer) Warning Signs”

10 Stomach Symptoms That Can Signal Cancer, COVID-19 Or Serious Disease

10 Stomach Symptoms That Can Signal Cancer, COVID-19 Or Serious Disease It’s not unusual to have an upset stomach after eating a spicy meal or feeling queasy when you have a stomach bug. However, there is cause for concern when the stomach grumbling that lasts for a few days turns into intense pain that lasts … Continue reading “10 Stomach Symptoms That Can Signal Cancer, COVID-19 Or Serious Disease”

Study Says Vegetarian Diets May Significantly Reduce Risk of Cancer, Heart Disease And Death

Study Says Vegetarian Diets May Significantly Reduce Risk of Cancer, Heart Disease And Death A diet rich in plants and plant-based foods significantly lowers the risks of developing cancer, heart disease, and dying early from cardiovascular disease, according to a large study that involved 23 years of data. Dr. Angelo Capodici, of the University of … Continue reading “Study Says Vegetarian Diets May Significantly Reduce Risk of Cancer, Heart Disease And Death”

Medicare’s First Ten Drugs Targeted For Price Cuts

Medicare’s First Ten Drugs Targeted For Price Cuts Millions of Medicare beneficiaries will have lower out-of-pocket costs for medication now that the nation’s single largest health program has the power to negotiate prescription drug prices directly with drug manufacturers. Medicare recipients who took the first 10 drugs selected for negotiations paid a total of $3.4 … Continue reading “Medicare’s First Ten Drugs Targeted For Price Cuts”